메뉴 건너뛰기




Volumn , Issue , 2015, Pages 35-52

BioSMB Technology as an Enabler for a Fully Continuous Disposable Biomanufacturing Platform

Author keywords

BioSMB technology; Disposable bioprocessing solution; Integrated continuous bioprocessing platform; Multicolumn chromatography

Indexed keywords

BATCH DATA PROCESSING;

EID: 84948968439     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527673681.ch02     Document Type: Chapter
Times cited : (5)

References (20)
  • 1
    • 84949051186 scopus 로고    scopus 로고
    • Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013
    • Brower, M. (2013) A simple strategy for continuous viral inactivation. Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013.
    • (2013) A simple strategy for continuous viral inactivation
    • Brower, M.1
  • 2
    • 84948995464 scopus 로고    scopus 로고
    • Continuous processing methods for biological products
    • Patent application WO/2012/078677
    • Ransohoff, T.C. and Bisschops, M.A.T. (2012) Continuous processing methods for biological products. Patent application WO/2012/078677.
    • (2012)
    • Ransohoff, T.C.1    Bisschops, M.A.T.2
  • 3
    • 0037224723 scopus 로고    scopus 로고
    • Virus inactivation in the 1990s - and into the 21st century. Part 4:Culture media, biotechnology products, and vaccines
    • Sofer, G. (2003) Virus inactivation in the 1990s - and into the 21st century. Part 4:Culture media, biotechnology products, and vaccines. BioPharm. Int., 16 (1), 50-57.
    • (2003) BioPharm. Int. , vol.16 , Issue.1 , pp. 50-57
    • Sofer, G.1
  • 4
    • 0037391331 scopus 로고    scopus 로고
    • Virus inactivation in the 1990s - and into the 21st century. Part 6:Inactivation methods grouped by virus
    • Sofer, G., Lister, D.C., and Boose, J.A. (2003) Virus inactivation in the 1990s - and into the 21st century. Part 6:Inactivation methods grouped by virus. BioPharm. Int., 16 (4), 42-68.
    • (2003) BioPharm. Int. , vol.16 , Issue.4 , pp. 42-68
    • Sofer, G.1    Lister, D.C.2    Boose, J.A.3
  • 5
    • 84868158860 scopus 로고    scopus 로고
    • Integrated continuous production of recombinant therapeutic proteins
    • Warikoo, V. et al. (2012) Integrated continuous production of recombinant therapeutic proteins. Biotechnol. Bioeng., 109, 3018-3029.
    • (2012) Biotechnol. Bioeng. , vol.109 , pp. 3018-3029
    • Warikoo, V.1
  • 7
    • 84920807117 scopus 로고    scopus 로고
    • The impact of continuous multicolumn chromatography on biomanufacturing efficiency
    • Bisschops, M. and Brower, M. (2013) The impact of continuous multicolumn chromatography on biomanufacturing efficiency. Pharm. Bioprocess., 1 (4), 361-372.
    • (2013) Pharm. Bioprocess. , vol.1 , Issue.4 , pp. 361-372
    • Bisschops, M.1    Brower, M.2
  • 9
    • 84949051188 scopus 로고    scopus 로고
    • IBC Biopharmaceutical Manufacturing and Development Conference, San Diego, CA, September 2011
    • Brower, M. (2011) Working towards an integrated antibody purification process. IBC Biopharmaceutical Manufacturing and Development Conference, San Diego, CA, September 2011.
    • (2011) Working towards an integrated antibody purification process
    • Brower, M.1
  • 12
    • 84949051191 scopus 로고    scopus 로고
    • Platform downstream processes in the age of continuous chromatography: a case study
    • Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013
    • Brower, M. (2013) Platform downstream processes in the age of continuous chromatography: a case study. Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013.
    • (2013)
    • Brower, M.1
  • 15
    • 0037168989 scopus 로고    scopus 로고
    • Effect of the homogeneity of the column set on the performance of a simulated moving bed unit. II. Experimental study
    • Mihlbachler, K., Jupke, A., Seidel-Morgenstern, A., Schmidt-Traub, H., and Guiochon, G. (2002) Effect of the homogeneity of the column set on the performance of a simulated moving bed unit. II. Experimental study. J. Chromatogr. A, 977, 3-22.
    • (2002) J. Chromatogr. A , vol.977 , pp. 3-22
    • Mihlbachler, K.1    Jupke, A.2    Seidel-Morgenstern, A.3    Schmidt-Traub, H.4    Guiochon, G.5
  • 18
    • 84863548879 scopus 로고    scopus 로고
    • Biotech facilities average a batch failure every 40.6 weeks
    • Langer, E. (2008) Biotech facilities average a batch failure every 40.6 weeks. Bioprocess Int., 6 (8), 28-29.
    • (2008) Bioprocess Int. , vol.6 , Issue.8 , pp. 28-29
    • Langer, E.1
  • 19
    • 84949051194 scopus 로고    scopus 로고
    • Biomanufacturing shows signs of maturity, PAT adoption
    • June 5, 2012
    • Langer, E. (2012) Biomanufacturing shows signs of maturity, PAT adoption. Pharmaceutical Manufacturing, June 5, 2012.
    • (2012) Pharmaceutical Manufacturing
    • Langer, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.